Prototyping kinase inhibitor-cytotoxin anticancer mutual prodrugs activated by tumour hypoxia: A chemical proof of concept study

被引:8
作者
Sansom, Geraud N. [1 ,2 ,3 ]
Kirk, Nicholas S. [1 ,2 ,3 ]
Guise, Christopher P. [4 ,5 ]
Anderson, Robert F. [4 ,5 ]
Smaill, Jeff B. [4 ,5 ]
Patterson, Adam, V [4 ,5 ]
Kelso, Michael J. [1 ,2 ,3 ]
机构
[1] Univ Wollongong, Mol Horizons, Wollongong, NSW 2522, Australia
[2] Univ Wollongong, Sch Chem & Mol Biosci, Wollongong, NSW 2522, Australia
[3] Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia
[4] Univ Auckland, Fac Med & Hlth Sci, Auckland Canc Soc, Res Ctr, Private Bag 92019, Auckland 1142, New Zealand
[5] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1142, New Zealand
基金
英国医学研究理事会;
关键词
Hypoxia; Mutual prodrug; Anticancer; Bioreductive activation; Sunitinib; Semaxinib; Floxuridine; 4-Aminoaniline mustard; NITRO REDUCTION; PHASE-II; DESIGN; SU5416; INDOLIN-2-ONES; DERIVATIVES; DELIVERY;
D O I
10.1016/j.bmcl.2019.03.015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Amide- and ester-linked kinase inhibitor-cytotoxin conjugates were rationally designed and synthesised as prototype hypoxia-activated anticancer mutual prodrugs. Chemical reduction of an aryl nitro trigger moiety was shown to initiate a spontaneous cyclisation/fragmentation reaction that simultaneously released the kinase inhibitor semaxanib (SU5416) and the amine- or alcohol-linked cytotoxin from the prodrugs. Preliminary cell testing and reduction potential measurements support optimisation of the compounds towards tumour-selective mutual prodrugs.
引用
收藏
页码:1215 / 1219
页数:5
相关论文
共 30 条
[1]   RELATIONSHIPS BETWEEN STRUCTURE AND KINETICS OF CYCLIZATION OF 2-AMINOARYL AMIDES - POTENTIAL PRODRUGS OF CYCLIZATION-ACTIVATED AROMATIC MUSTARDS [J].
ATWELL, GJ ;
SYKES, BM ;
OCONNOR, CJ ;
DENNY, WA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (03) :371-380
[2]   Prodrug-based intracellular delivery of anticancer agents [J].
Bildstein, L. ;
Dubernet, C. ;
Couvreur, P. .
ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (1-2) :3-23
[3]   Indolin-2-ones with high in vivo efficacy in a model for multiple sclerosis [J].
Bouérat, L ;
Fensholdt, J ;
Liang, XF ;
Havez, S ;
Nielsen, SF ;
Hansen, JR ;
Bolvig, S ;
Andersson, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (17) :5412-5414
[4]   Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy [J].
Chari, RVJ .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 31 (1-2) :89-104
[5]   Design of Anticancer Prodrugs for Reductive Activation [J].
Chen, Yu ;
Hu, Longqin .
MEDICINAL RESEARCH REVIEWS, 2009, 29 (01) :29-64
[6]   Prodrug strategies in cancer therapy [J].
Denny, WA .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (7-8) :577-595
[7]   Hypoxia-activated prodrugs in cancer therapy: progress to the clinic [J].
Denny, William A. .
FUTURE ONCOLOGY, 2010, 6 (03) :419-428
[8]   Rapid and inexpensive method for reduction of nitroarenes to anilines [J].
Desai, DG ;
Swami, SS ;
Hapase, SB .
SYNTHETIC COMMUNICATIONS, 1999, 29 (06) :1033-1036
[9]   A Click Chemistry Approach to Pleuromutilin Derivatives, Part 2: Conjugates with Acyclic Nucleosides and Their Ribosomal Binding and Antibacterial Activity [J].
Dreier, Ida ;
Kurnar, Surender ;
Sondergaard, Helle ;
Rasmussen, Maria Louise ;
Hansen, Lykke Haastrup ;
List, Nanna Holmgaard ;
Kongsted, Jacob ;
Vester, Birte ;
Nielsen, Poul .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (05) :2067-2077
[10]   Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial [J].
Facon, Thierry ;
Mary, Jean Yves ;
Hulin, Cyrille ;
Benbouker, Lofti ;
Attal, Michel ;
Pegourie, Brigitte ;
Renaud, Marc ;
Guillerm, Jean Luc Harousseau Gaelle ;
Ahletaix, Carine ;
Dib, Mamoun ;
Voillat, Laurent ;
Maisonneuve, Herve ;
Troncy, Jacques ;
Dervaux, Weronique ;
Monconduit, Mathieu ;
Martin, Claude ;
Casassus, Philippe ;
Jaubert, Jerome ;
Jardel, Henry ;
Doyen, Chantal ;
Kolb, Brigitte ;
Anglaret, Bruno ;
Grosbois, Bernard ;
Yakoub-Agha, Ibrahim ;
Mathiot, Claire ;
Avet-Loiseau, Herve .
LANCET, 2007, 370 (9594) :1209-1218